Synfacts 2024; 20(07): 0765
DOI: 10.1055/s-0043-1763970
Innovative Drug Discovery and Development

A Classic Route to the Synthesis of Tamiflu®

Contributor(s):
Dirk Trauner
,
Jordan Y. Artzy
Abrecht S, Harrington P, Iding H, Karpf M, *, Trussardi R, Wirz B, Zutter U. F. Hoffmann-La Roche Ltd, Basel, Switzerland
The Synthetic Development of the Anti–influenza Neuraminidase Inhibitor Oseltamivir Phosphate (Tamiflu®): A Challenge for Synthesis & Process Research.

Chimia 2004;
58: 621-629
DOI: 10.2533/000942904777677605.
 

Significance

Tamiflu®, or oseltamivir, is vital for treating and preventing influenza infections caused by influenza A and B viruses, as it reduces symptom severity and duration when taken within 48 hours of symptom onset. It also serves as a prophylactic measure to prevent influenza in those exposed to the virus and helps in controlling transmission, especially during outbreaks and pandemics. Crucially, Tamiflu® is particularly important for vulnerable populations, such as the elderly and those with underlying health conditions and plays a key role in pandemic preparedness efforts.


#

Comment

The synthesis commences with inexpensive 1,6-dimethoxyphenol. Key steps to the synthesis of oseltamivir rely on an all-cis hydrogenation of the electron-rich aryl ring to access five stereocenters in a single step. A desymmetrization enables access to an enantioenriched chiral building block by enzymatic hydrolysis. A key decarboxylative elimination sequence affords the α,β-unsaturated ester in high yield. While there are causes for concern in terms of scalability (i.e. high pressure carbonylations, hydrogenations and the use of azides) this synthesis is arguably a masterclass in the field of synthetic chemistry.


#
#

Publication History

Article published online:
14 June 2024

© 2024. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany